comparemela.com
Home
Live Updates
Arbutus Announces CEO, William Collier, to Retire December 31, 2023 - Arbutus Biopharma (NASDAQ:ABUS) : comparemela.com
Arbutus Announces CEO, William Collier, to Retire December 31, 2023 - Arbutus Biopharma (NASDAQ:ABUS)
Michael J. McElhaugh, Arbutus Co-founder and COO, to Serve as Interim CEO WARMINSTER, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (NASDAQ:ABUS) ("Arbutus" or the "Company"), a clinical-stage
Related Keywords
Canada ,
Canadian ,
William Collier ,
Frank Torti ,
Michaelj Mcelhaugh ,
Lisam Caperelli ,
Oncore Biopharma ,
Mike Mcelhaugh ,
Bristol Myers Squibb ,
Securities Exchange ,
Business Development ,
Market Analytics At Pharmasset Inc ,
Gilead Sciences Inc ,
Thomas Jefferson University ,
Arbutus Biopharma Corporation ,
Joseph University ,
Viropharma Inc ,
Co Inc ,
Arbutus Co Founder ,
Chief Executive Officer ,
Chief Operating Officer ,
Interim President ,
Chief Business Officer ,
Senior Vice President ,
Commercial Strategy ,
Chief Operating ,
Hepatitisc Worldwide Commercialization ,
Market Analytics ,
Gilead Sciences ,
Johnson Graduate School ,
Looking Statements ,
Securities Act ,
Securities Exchange Act ,
Arbutu Annual Report ,
Arbutu Quarterly Reports ,
comparemela.com © 2020. All Rights Reserved.